Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(6):407-409; doi:10.1093/jnci/dji085
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Engels, E. A.
Right arrow Articles by Goedert, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engels, E. A.
Right arrow Articles by Goedert, J. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

EDITORIAL

Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Cancer: Past, Present, and Future

Eric A. Engels, James J. Goedert

Affiliations of authors: Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Rockville, MD

Correspondence to: James J. Goedert, MD, Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, DHHS, 6120 Executive Blvd, EPS 8012, Rockville, MD 20892 (e-mail: goedertj@mail.nih.gov).

The first 10% of the full text of this article appears below.

From the beginning of the human immunodeficiency virus (HIV) epidemic in 1981, it has been apparent that people infected with this virus have an elevated risk for certain cancers, most notably Kaposi sarcoma (KS) and non-Hodgkin lymphoma. Indeed, it was the explosive outbreak of KS among young homosexual men in New York City and California that signaled the onset of the epidemic. HIV induces clinical disease, the acquired immunodeficiency syndrome (AIDS), by causing progressive depletion of CD4+ T lymphocytes, the linchpin of the cell-mediated immune system. Only since 1996 have we had effective HIV/AIDS treatment, in the form of highly active antiretroviral therapy (HAART), that can markedly suppress the replication of HIV, partially restore immunity, reduce morbidity, and extend life (1).

The HIV epidemic has . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 GutHome page
E J Bini, B Green, and M A Poles
Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects
Gut, August 1, 2009; 58(8): 1129 - 1134.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
N Mourra, M-G Lebrette, C Hoeffel, and F Paye
Gallbladder adenocarcinoma: first report in a patient with AIDS
J. Clin. Pathol., May 1, 2008; 61(5): 688 - 688.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Negin, D. Panka, W. Wang, M. Siddiqui, N. Tawa, J. Mullen, S. Tahan, L. Mandato, A. Polivy, J. Mier, et al.
Effect of Melanoma on Immune Function in the Regional Lymph Node Basin
Clin. Cancer Res., February 1, 2008; 14(3): 654 - 659.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
B. J. Byrne and J. P. Gockerman
Salvage Therapy in Hodgkin's Lymphoma
Oncologist, February 1, 2007; 12(2): 156 - 167.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Carde
The Chemotherapy/Radiation Balance in Advanced Hodgkin's Lymphoma: Overweight Which Side?
J. Clin. Oncol., December 20, 2005; 23(36): 9058 - 9062.
[Full Text] [PDF]